Literature DB >> 16416395

Microglial cells in neurodegenerative disorders.

Marcin Wojtera1, Beata Sikorska, Tomasz Sobow, Paweł P Liberski.   

Abstract

Microglia are resident immune cells of the CNS. They are involved in the pathogenesis of diverse neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, prion diseases as well as multiple sclerosis, amyotrophic lateral sclerosis and AIDS dementia complex. It is widely accepted that microglia contribute to the neurodegeneration through a release of a variety of proinflammatory substances. In fact, they are not the only cells which contribute to immunological processes inside the nervous system. The CNS is composed of different cell populations that answer to pathological factors and influence each other and modulate their reactions. These complex interactions are responsible for the development of brain pathology. This paper reviews the available information on microglial cells contribution to AD, PD and prion diseases development.

Entities:  

Mesh:

Year:  2005        PMID: 16416395

Source DB:  PubMed          Journal:  Folia Neuropathol        ISSN: 1509-572X            Impact factor:   2.038


  32 in total

Review 1.  Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention.

Authors:  Malú G Tansey; Melissa K McCoy; Tamy C Frank-Cannon
Journal:  Exp Neurol       Date:  2007-07-17       Impact factor: 5.330

2.  Maternal Hyperhomocysteinemia Induces Neuroinflammation and Neuronal Death in the Rat Offspring Cortex.

Authors:  A D Shcherbitskaia; D S Vasilev; Yu P Milyutina; N L Tumanova; I V Zalozniaia; G O Kerkeshko; A V Arutjunyan
Journal:  Neurotox Res       Date:  2020-06-05       Impact factor: 3.911

3.  Protease-activated receptor-1 expression in rat microglia after trimethyltin treatment.

Authors:  Elena Pompili; Cinzia Fabrizi; Stefania Lucia Nori; Barbara Panetta; Maria Concetta Geloso; Valentina Corvino; Fabrizio Michetti; Lorenzo Fumagalli
Journal:  J Histochem Cytochem       Date:  2011-01-12       Impact factor: 2.479

4.  PKCδ mediates paraquat-induced Nox1 expression in dopaminergic neurons.

Authors:  Ana Clara Cristóvão; Joana Barata; Goun Je; Yoon-Seong Kim
Journal:  Biochem Biophys Res Commun       Date:  2013-07-02       Impact factor: 3.575

5.  Nanolipidic particles improve the bioavailability and alpha-secretase inducing ability of epigallocatechin-3-gallate (EGCG) for the treatment of Alzheimer's disease.

Authors:  Adam Smith; Brian Giunta; Paula C Bickford; Michael Fountain; Jun Tan; R Douglas Shytle
Journal:  Int J Pharm       Date:  2010-01-18       Impact factor: 5.875

6.  Microglia induce neurotoxicity via intraneuronal Zn(2+) release and a K(+) current surge.

Authors:  Megan E Knoch; Karen A Hartnett; Hirokazu Hara; Karl Kandler; Elias Aizenman
Journal:  Glia       Date:  2008-01-01       Impact factor: 7.452

7.  Doxycycline Suppresses Microglial Activation by Inhibiting the p38 MAPK and NF-kB Signaling Pathways.

Authors:  Flávia V Santa-Cecília; Benjamin Socias; Mohand O Ouidja; Julia E Sepulveda-Diaz; Leonardo Acuña; Rangel L Silva; Patrick P Michel; Elaine Del-Bel; Thiago M Cunha; Rita Raisman-Vozari
Journal:  Neurotox Res       Date:  2016-01-08       Impact factor: 3.911

8.  Signal regulatory protein-beta1: a microglial modulator of phagocytosis in Alzheimer's disease.

Authors:  Sadanand Gaikwad; Sergey Larionov; Yiner Wang; Holger Dannenberg; Takashi Matozaki; Alon Monsonego; Dietmar R Thal; Harald Neumann
Journal:  Am J Pathol       Date:  2009-11-05       Impact factor: 4.307

9.  Prion protein expression differences in microglia and astroglia influence scrapie-induced neurodegeneration in the retina and brain of transgenic mice.

Authors:  Lisa Kercher; Cynthia Favara; James F Striebel; Rachel LaCasse; Bruce Chesebro
Journal:  J Virol       Date:  2007-07-25       Impact factor: 5.103

10.  Intrathecal corticosteroids might slow Alzheimer's disease progression.

Authors:  Joseph Martin Alisky
Journal:  Neuropsychiatr Dis Treat       Date:  2008-10       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.